MRMD News and Press, MariMed Inc From 10/01/25

NORWOOD, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- InHouse™ announced today the launch of its second annual Help on the Homefront campaign, a philanthropic effort that provides veterans the chance to win funds to help offset their cost of housing or home improvements. Help on ...

NORWOOD, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) -- MariMed Inc . (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report its third quarter 2025 financial results on Nove...

NORWOOD, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Betty’s Eddies™ announced its third annual collaboration with the Keep A Breast Foundation (“KAB”), furthering its commitment to breast cancer awareness, early screening education, and community support. After ...

2025-09-02 00:59:07 ET Introduction Since mid-year, the Twittersphere has been replete with comments that cannabis was about to be moved from a Schedule 1 to a Schedule 3 substance. Those comments gained increased credibility on August 11th when President Trump said his administrati...

2025-08-09 16:10:52 ET Related stories Aurora Cannabis: Downgrading On Regulatory Headwinds And Competitive Pressures - Hold TerrAscend Corp. (TSNDF) Q2 2025 Earnings Call Transcript TerrAscend Corp. 2025 Q2 - Results - Earnings Call Presentation Canopy Growt...

2025-08-07 22:24:40 ET More on MariMed MariMed Inc. (MRMD) Q2 2025 Earnings Call Transcript Seeking Alpha’s Quant Rating on MariMed Historical earnings data for MariMed Financial information for MariMed Read the full article on Seeking Alpha ...

2025-08-07 22:24:11 ET MariMed Inc. (MRMD) Q2 2025 Earnings Conference Call August 07, 2025, 08:00 AM ET Company Participants Jake Dean - Director of Research and Development Jon R. Levine - Co-Founder, CEO, President, Secretary, Treasurer & Director Mario Pi...

2025-08-07 10:05:11 ET More on MariMed Seeking Alpha’s Quant Rating on MariMed Historical earnings data for MariMed Financial information for MariMed Read the full article on Seeking Alpha For further details see: MariMed reports Q2 results

NORWOOD, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the second quarter ended J...

Sera Prognostics Inc. (SERA) is expected to report $-0.21 for Q2 2025 D/B/A Compass Diversified Holdings Shares of Beneficial Interest (CODI) is expected to report $0.51 for Q2 2025 Context Therapeutics Inc. (CNTX) is expected to report $-0.06 for Q2 2025 Genco Shipping & Trading ...